BNP PARIBAS FINANCIAL MARKETS - MERIDIAN BIOSCIENCE INC ownership

MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 194 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of MERIDIAN BIOSCIENCE INC
ValueSharesWeighting
Q4 2022$228,584
-100.0%
6,883
-53.7%
0.00%
-100.0%
Q3 2022$468,315,000
-20.9%
14,853
-23.7%
0.00%0.0%
Q2 2022$592,034,000
-58.2%
19,462
-64.3%
0.00%
-50.0%
Q1 2022$1,415,443,000
+45.3%
54,524
+14.2%
0.00%
+100.0%
Q4 2021$974,304,000
+12.5%
47,760
+6.1%
0.00%0.0%
Q3 2021$865,935,000
+91.6%
45,007
+120.9%
0.00%0.0%
Q2 2021$451,851,000
+22.9%
20,372
+45.4%
0.00%0.0%
Q1 2021$367,684,000
+51.1%
14,007
+7.6%
0.00%
Q4 2020$243,269,000
+30.9%
13,016
+18.9%
0.00%
Q3 2020$185,863,000
+105.9%
10,946
+182.5%
0.00%
Q2 2020$90,249,000
-39.7%
3,875
-78.2%
0.00%
Q1 2020$149,638,000
+47.0%
17,814
+71.0%
0.00%
Q4 2019$101,784,000
+41.2%
10,418
+37.1%
0.00%
Q3 2019$72,105,000
-30.0%
7,598
-12.4%
0.00%
Q2 2019$103,047,000
-39.6%
8,674
-10.5%
0.00%
Q1 2019$170,606,000
+304.4%
9,688
+298.7%
0.00%
Q4 2018$42,185,000
+12.4%
2,430
-3.5%
0.00%
Q3 2018$37,533,000
-66.1%
2,519
-63.8%
0.00%
Q2 2018$110,712,000
-89.7%
6,963
-90.8%
0.00%
-100.0%
Q1 2018$1,080,024,000
-3.5%
76,058
-4.8%
0.00%0.0%
Q4 2017$1,118,880,000
+253.7%
79,920
+261.3%
0.00%
+100.0%
Q3 2017$316,359,000
+34.8%
22,123
+48.5%
0.00%0.0%
Q2 2017$234,707,000
+97.0%
14,902
+72.6%
0.00%
Q1 2017$119,135,000
-12.3%
8,633
+12.5%
0.00%
-100.0%
Q4 2016$135,812,000
-4.7%
7,673
+3.9%
0.00%0.0%
Q3 2016$142,495,000
-48.1%
7,387
-47.5%
0.00%0.0%
Q2 2016$274,424,000
+90.3%
14,073
+101.2%
0.00%0.0%
Q1 2016$144,188,000
-24.8%
6,996
-25.1%
0.00%
Q4 2015$191,738,000
+28.7%
9,344
+7.3%
0.00%
Q3 2015$148,941,000
+119.2%
8,710
+138.9%
0.00%
Q2 2015$67,961,000
+258.3%
3,646
+266.8%
0.00%
Q1 2015$18,966,000
-56.2%
994
-59.3%
0.00%
Q3 2014$43,252,000
+1269.6%
2,445
+1498.0%
0.00%
Q2 2014$3,158,000
-77.8%
153
-71.5%
0.00%
Q4 2013$14,247,000
-94.6%
537
-95.2%
0.00%
Q3 2013$263,522,000
-15.2%
11,152
-22.9%
0.00%
Q2 2013$310,890,00014,4600.00%
Other shareholders
MERIDIAN BIOSCIENCE INC shareholders Q4 2020
NameSharesValueWeighting ↓
SYQUANT CAPITAL SAS 134,804$4,47711.01%
Vazirani Asset Management LLC 115,774$3,8456.51%
FIFTH LANE CAPITAL, LP 185,914$6,174,2045.56%
NEXPOINT ASSET MANAGEMENT, L.P. 1,939,075$64,396,6815.01%
Crystalline Management Inc. 244,453$8,118,2844.08%
FNY Investment Advisers, LLC 51,000$1,6932.36%
HAVENS ADVISORS LLC 26,800$890,0282.26%
Euclidean Technologies Management, LLC 62,995$2,092,0641.99%
Sand Grove Capital Management LLP 537,060$17,8361.70%
Crabel Capital Management, LLC 120,337$3,9961.45%
View complete list of MERIDIAN BIOSCIENCE INC shareholders